207_Combined course Presentations

Molecular “status” overcomes treatment strategy…

Favourable

Unfavourable

RTOG 9402 Cairncross JG. et al. JCO 2014;32

IDH1 wt

IDH1 mutated

EORTC 26951 Van den Bent MJ. et al. JCO 2013;31

1p/19q NON codeleted

1p/19q codeleted

…can we consider RT + PCV as standard of care ?